Gilead Jumps Out Ahead of BMS in Second-Line B-Cell Lymphoma

Kite Pharma, a subsidiary of Gilead, announced that Yescarta (axicabtagene ciloleucel), a chimeric antigen receptor (CAR) T-cell therapy, has been approved by the U.S. Food and Dru...

Learn More

Weekly Policy Update: State Regulation of PFAS

The regulatory environment regarding the usage of perfluoroalkyl and polyfluoroalkyl chemicals (PFAS) in medical devices and other products is evolving to include potential action on the state level....

Learn More

GelSana Therapeutics Wins UNC Entrepreneurial Challenge

The University of Northern Colorado's Monfort College of Business has announced the winners of the 2022 Entrepreneurial Challenge. After making improvements to their business plans based on judges’ fe...

Learn More

Enveda Biosciences Adds Drug Development Leaders to Scale Efforts and Accelerate Progress

Enveda Biosciences, a leading biotechnology company harnessing nature’s chemistry to develop next-generation small molecule therapies, today announced the addition of three leaders to further scale an...

Learn More

Colorado's Women-founded Startups Make Huge Strides

CBSA member Inscipta is mentioned in Colorado's startups success. In a record year for venture capital in Colorado, firms founded by women saw sizable gains, too. Why it matters: The VC...

Learn More

U.S. FDA Clears Terumo Blood and Cell Technologies' New Plasma Collection Technology

The U.S. Food and Drug Administration (FDA) cleared the new plasma collection system developed by Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company. Rika is a next-generati...

Learn More

SmartTab Named as a Finalist at SXSW

CBSA Member SmartTab was named a Finalist in Health, Wearables, and Wellbring at SXSW. Congratualtions! SmartTabDenver, CO SmartTab is developing an advanced platform of ingestible capsules for oral d...

Learn More

Companies Bet You’re Ready to Test at Home for More Than Covid-19

The Covid-19 pandemic has hastened consumers’ willingness to test for more medical conditions at home, test makers said, expanding the market for self-diagnostic products. Manufacturers are devel...

Learn More

LightDeck Diagnostics and The Henry M. Jackson Foundation for the Advancement of Military Medicine receive $2M To Develop Rapid, Multiplexed Inflammation Test for Respiratory Illness

LightDeck Diagnostics, the company leveraging planar waveguide technology to deliver lab-quality diagnostics in minutes, today received a $2M contract from HJF, as funded by the Joint Program Exe...

Learn More

Colorado coalition a semifinalist for $100 million industry-building grant

The grant, if won, would allow for construction of bioscience and cleantech projects throughout the Denver, Boulder and Fort Collins areas — and the development of programs to improve the pipelines of...

Learn More